NIMBEX

This brand name is authorized in United States. It is also authorized in Austria, Cyprus, Finland, France, Hong Kong SAR China, Ireland, Lithuania, Mexico, Netherlands, Poland, Singapore, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug NIMBEX contains one active pharmaceutical ingredient (API):

1
UNII 80YS8O1MBS - CISATRACURIUM BESYLATE
 

Cisatracurium is an intermediate-duration, non-depolarising benzylisoquinolinium skeletal muscle relaxant. Cisatracurium binds to cholinergic receptors on the motor end-plate to antagonise the action of acetylcholine, resulting in a competitive block of neuromuscular transmission. This action is readily reversed by anti-cholinesterase agents such as neostigmine or edrophonium.

 
Read more about Cisatracurium

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 NIMBEX Solution for injection / infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M03AC11 Cisatracurium M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AC Other quaternary ammonium compounds
Discover more medicines within M03AC11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
ES Centro de información online de medicamentos de la AEMPS 61199, 61200
FI Lääkealan turvallisuus- ja kehittämiskeskus 150706, 150714, 150797, 150979
FR Base de données publique des médicaments 60224800, 68123109
GB Medicines & Healthcare Products Regulatory Agency 48523, 48527
HK Department of Health Drug Office 42333
LT Valstybinė vaistų kontrolės tarnyba 1011836, 1011837
MX Comisión Federal para la Protección contra Riesgos Sanitarios 371M97
NL Z-Index G-Standaard, PRK 128341, 128368, 46337
PL Rejestru Produktów Leczniczych 100086100
SG Health Sciences Authority 14309P, 14310P
TN Direction de la Pharmacie et du Médicament 15493061H, 15493062H
US FDA, National Drug Code 0074-4378, 0074-4380, 0074-4382
ZA Health Products Regulatory Authority 31/17.1/0256, 31/17.1/0445

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.